How to screen NAFLD patients for diabetes?

被引：0
|
作者：
Gonzalez-Moreno, Emmanuel I. [1 ]
García-Compean, Diego [1 ]
Gonzalez-Gonzalez, Jose A. [1 ]
Maldonado-Garza, Hector J. [1 ]
机构：
[1] Univ Hosp, Univ Autonoma Nuevo Leon, Dept Internal Med, Div Gastroenterol, Madero & Gonzalitos S-N, Mexico City 64460, DF, Mexico
来源：
ANNALS OF HEPATOLOGY | 2016年 / 15卷 / 05期
关键词：
FATTY LIVER-DISEASE; MELLITUS;
D O I：
10.5604/16652681.1212623
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：801 / 802
页数：2
相关论文
共 50 条
  • [21] Is there an 'ideal' diet for patients with NAFLD?
    Pugliese, Nicola
    Torres, Maria Corina Plaz
    Petta, Salvatore
    Valenti, Luca
    Giannini, Edoardo G.
    Aghemo, Alessio
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2022, 52 (03)
  • [22] Prevalence of non-alcoholic fatty liver disease (NAFLD) in a cohort of patients with type 2 diabetes: the PHIGNA-Dm2 study
    Jesus Martinez-Ortega, Antonio
    Pinar Gutierrez, Ana
    Lara-Romero, Carmen
    Remon Ruiz, Pablo Jesus
    Ampuero-Herrojo, Javier
    De Lara-Rodriguez, Irene
    Romero-Gomez, Manuel
    Luna, Pedro P. Garcia
    Soto-Moreno, Alfonso
    NUTRICION HOSPITALARIA, 2022, 39 (05) : 1012 - 1018
  • [23] NAFLD as a continuum: from obesity to metabolic syndrome and diabetes
    Godoy-Matos, Amelio F.
    Silva Junior, Wellington S.
    Valerio, Cynthia M.
    DIABETOLOGY & METABOLIC SYNDROME, 2020, 12 (01)
  • [24] Diabetes and pre-diabetes among household contacts of tuberculosis patients in India: is it time to screen them all?
    Shivakumar, S. V. B. Y.
    Chandrasekaran, P.
    Kumar, A. M., V
    Paradkar, M.
    Dhanasekaran, K.
    Suryavarshini, N.
    Thomas, B.
    Kohli, R.
    Thiruvengadam, K.
    Kulkarni, V
    Hannah, L. E.
    Sivaramakrishnan, G. N.
    Pradhan, N.
    Dolla, C.
    Gupte, A.
    Ramachandran, G.
    DeLuca, A.
    Meshram, S.
    Bhardawaj, R.
    Bollinger, R. C.
    Golub, J.
    Selvaraj, K.
    Gupte, N.
    Swaminathan, S.
    Mave, V
    Gupta, A.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2018, 22 (06) : 686 - +
  • [25] Why Does NAFLD Predict Type 2 Diabetes?
    Lattuada, Guido
    Ragogna, Francesca
    Perseghin, Gianluca
    CURRENT DIABETES REPORTS, 2011, 11 (03) : 167 - 172
  • [26] The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: A systematic review and meta-analysis
    Younossi, Zobair M.
    Golabi, Pegah
    de Avila, Leyla
    Paik, James Minhui
    Srishord, Manirath
    Fukui, Natsu
    Qiu, Ying
    Burns, Leah
    Afendy, Arian
    Nader, Fatema
    JOURNAL OF HEPATOLOGY, 2019, 71 (04) : 793 - 801
  • [27] How Inflammation Impinges on NAFLD: A Role for Kupffer Cells
    Duarte, Nadia
    Coelho, Ines C.
    Patarrao, Rita S.
    Almeida, Joana I.
    Penha-Goncalves, Carlos
    Paula Macedo, M.
    BIOMED RESEARCH INTERNATIONAL, 2015, 2015
  • [28] Do Hospital Doctors Screen for Diabetes?
    Mean, Marie
    Waeber, Gerard
    Marques-Vidal, Pedro
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2019, 127 (08) : 511 - 516
  • [29] Is diabetes distress on your radar screen?
    Beverly, Elizabeth A.
    Ivanov, Nedyalko N.
    Court, Autumn B.
    Fredricks, Todd R.
    JOURNAL OF FAMILY PRACTICE, 2017, 66 (01) : 9 - 14
  • [30] Multimorbidity and polypharmacy in diabetic patients with NAFLD: Implications for disease severity and management
    Patel, Preya Janubhai
    Hayward, Kelly Lee
    Rudra, Rathiga
    Horsfall, Leigh Ula
    Hossain, Fabrina
    Williams, Suzanne
    Johnson, Tracey
    Brown, Nigel Neil
    Saad, Nivene
    Clouston, Andrew Donald
    Stuart, Katherine Anne
    Valery, Patricia Casarolli
    Irvine, Katharine Margaret
    Russell, Anthony William
    Powell, Elizabeth Ellen
    MEDICINE, 2017, 96 (26)
12345